Traders bought shares of Monsanto Co. (NYSE:MON) on weakness during trading on Thursday after an insider sold shares in the company. $52.34 million flowed into the stock on the tick-up and $36.69 million flowed out of the stock on the tick-down, for a money net flow of $15.65 million into the stock. Of all companies tracked, Monsanto had the 19th highest net in-flow for the day. Monsanto traded down ($0.07) for the day and closed at $100.66Specifically, EVP Kerry J. Preete sold 2,745 shares of the company’s stock in a transaction on Thursday, November 17th. The stock was sold at an average price of $100.96, for a total value of $277,135.20. Following the completion of the sale, the executive vice president now directly owns 50,056 shares in the company, valued at approximately $5,053,653.76. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, EVP Steven Mizell sold 310 shares of the company’s stock in a transaction on Monday, October 10th. The shares were sold at an average price of $103.09, for a total value of $31,957.90. The disclosure for this sale can be found here. 0.88% of the stock is owned by corporate insiders.

Several analysts have issued reports on the company. Jefferies Group restated a “buy” rating on shares of Monsanto in a report on Tuesday, September 6th. Zacks Investment Research upgraded Monsanto from a “strong sell” rating to a “hold” rating in a report on Tuesday, September 6th. Monness Crespi & Hardt upgraded Monsanto from a “neutral” rating to a “buy” rating and upped their target price for the company from $106.93 to $130.00 in a report on Monday, August 8th. Sanford C. Bernstein reiterated a “sell” rating on shares of Monsanto in a report on Thursday, September 15th. Finally, BMO Capital Markets set a $128.00 price target on Monsanto and gave the stock a “buy” rating in a report on Thursday, September 15th. Three analysts have rated the stock with a sell rating, eight have issued a hold rating, fourteen have assigned a buy rating and one has given a strong buy rating to the company. The stock has a consensus rating of “Buy” and a consensus target price of $114.65.

The stock has a market cap of $44.33 billion, a P/E ratio of 33.87 and a beta of 1.01. The company has a 50-day moving average of $101.15 and a 200-day moving average of $103.51.

Monsanto (NYSE:MON) last issued its earnings results on Wednesday, October 5th. The company reported $0.07 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.02) by $0.09. Monsanto had a return on equity of 46.07% and a net margin of 9.89%. The company earned $2.56 billion during the quarter, compared to the consensus estimate of $2.38 billion. During the same quarter in the prior year, the business earned ($0.19) earnings per share. The company’s revenue was up 8.8% compared to the same quarter last year. On average, equities research analysts expect that Monsanto Co. will post $4.73 EPS for the current year.

Several large investors have recently modified their holdings of the company. TT International increased its stake in shares of Monsanto by 5.2% in the second quarter. TT International now owns 28,731 shares of the company’s stock valued at $2,971,000 after buying an additional 1,408 shares during the last quarter. Exxonmobil Investment Management Inc. TX increased its position in shares of Monsanto by 5.5% in the second quarter. Exxonmobil Investment Management Inc. TX now owns 113,077 shares of the company’s stock worth $11,693,000 after buying an additional 5,861 shares in the last quarter. DNB Asset Management AS increased its position in shares of Monsanto by 0.7% in the second quarter. DNB Asset Management AS now owns 91,457 shares of the company’s stock worth $9,458,000 after buying an additional 600 shares in the last quarter. British Columbia Investment Management Corp increased its position in shares of Monsanto by 16.5% in the second quarter. British Columbia Investment Management Corp now owns 201,105 shares of the company’s stock worth $20,796,000 after buying an additional 28,500 shares in the last quarter. Finally, Baxter Bros Inc. acquired a new position in shares of Monsanto during the second quarter worth approximately $2,876,000. 78.72% of the stock is owned by institutional investors.

About Monsanto

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

5 Day Chart for NYSE:MON

Receive News & Stock Ratings for Monsanto Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Co. and related stocks with our FREE daily email newsletter.